XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 28 Months Ended
Jun. 18, 2020
Apr. 02, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Mar. 31, 2020
Sep. 28, 2017
Allowance for doubtful accounts     $ 117,094   $ 117,094   $ 117,094 $ 62,248  
Amortization of other intangible assets     357,111 $ 249,794 1,071,335 $ 729,131      
Impairment expense          
Concentration Percentage     10.00% 10.00% 10.00% 10.00%      
Advertising expenses     $ 51,700 $ 128,709 $ 190,277 $ 422,948      
Income tax, description         We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized.        
Contingencies            
Warrants [Member]                  
Antidilutive securities excluded from computation of earnings per share, amount         8,910,205        
Weighted average diluted common shares outstanding         8,910,205 8,629,432      
Employees, Members of Board of Directors and Advisory Committee [member]                  
Number of shares issued for services     137,916            
Minimum [Member]                  
Property and equipment useful life         5 years        
Maximum [Member]                  
Property and equipment useful life         10 years        
Federal deposit insurance corporation limit     $ 250,000   $ 250,000   $ 250,000    
Patents [Member]                  
Patent amortization expense     21,269 21,268 $ 63,806 $ 63,806      
License agreement term, description         This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.        
Royalty expense     70,793 20,261          
Patents [Member] | SW Kenetics Inc. [Member]                  
Patent amortization expense     102,067 102,067 $ 306,200 239,253      
Hallam, Inc [Member]                  
Ownership percentage in ATI                 100.00%
License agreement term, description         Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028        
Licensing Agreements [Member]                  
Amortization expense     $ 12,500 $ 37,500 $ 12,500 $ 37,500      
Employment agreement [Member] | Robert D. Wiley [Member]                  
Option granted   33,333              
Options vesting in period   8,333              
Vesting period   3 years              
Employment agreement [Member] | Steve Hilko [Member]                  
Option granted 33,333                
Options vesting in period 8,333                
Vesting period 3 years                
Employment agreement [Member] | Four Separate Employee Agreements [Member]                  
Option granted             540,382    
Vesting period             3 years    
Employment agreement [Member] | Maximum [Member] | Four Separate Employee Agreements [Member]                  
Vesting period             4 years